STUDIES OF THE IMMUNOGENICITY, COMMUNICABILITY AND GENETIC STABILITY OF ORAL POLIOVACCINE ADMINISTERED DURING THE WINTER1

BENYESH-MELNICK, M.; MELNICK, J. L.; RAWLS, W. E.; WIMBERLY, I.; ORO, J. BARRERA; BEN-PORATH, E.; RENNICK, V.

doi:10.1093/oxfordjournals.aje.a120717

Cited by 93Viral Infections and Immunology ResearchVirology and Viral DiseasesViral gastroenteritis research and epidemiology

STUDIES OF THE IMMUNOGENICITY, COMMUNICABILITY AND GENETIC STABILITY OF ORAL POLIOVACCINE ADMINISTERED DURING THE WINTER1

BENYESH-MELNICK, M., MELNICK, J. L., RAWLS, W. E., WIMBERLY, I., ORO, J. BARRERA, BEN-PORATH, E., RENNICK, V.·1967·American Journal of Epidemiology

DOI 10.1093/oxfordjournals.aje.a120717

Open this paper in CoChat — free account

Abstract

M. BENYESH-MELNICK, J. L. MELNICK, W. E. RAWLS, I. WIMBERLY, J. BARRERA ORO, E. BEN-PORATH, V. RENNICK; STUDIES OF THE IMMUNOGENICITY, COMMUNICABILITY AND

Integrity signals

Registry

Crossref · 10.1093/oxfordjournals.aje.a120717

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The live, attenuated oral poliovirus vaccine (OPV) is genetically unstable.
“The live, attenuated oral poliovirus vaccine (OPV), used for more than four decades to interrupt poliovirus transmission, and the vaccine of choice for developing countries, is genetically unstable.”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [11]
The genetic stability of OPV was a major concern before and after licensure.
“The genetic stability of OPV was a major concern before (143, 144) and after (11) licensure.”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [11]
The increased risk for type 2 VDPVs probably results from the greater tendency of the type 2 vaccine strain to spread to household and community contacts.
“The increased risk for type 2 VDPVs probably results from the greater tendency of the type 2 vaccine strain to spread to household (11, 55) and community contacts”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [11]

Sorted by citations

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703 · see citing works
Transmissibility and Persistence of Oral Polio Vaccine Viruses: Implications for the Global Poliomyelitis Eradication Initiative
Fine, P. E. M., & Carneiro, I. A. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009924 · Cited by 247 · see citing works
“A comparison of consecutive (second- and third-degree) contacts of vaccinees (siblings and contacts of siblings) found similar phenotypic reversion frequencies in viruses excreted by vaccinees and contacts (41).”
BackgroundMethodResult
Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature.
Alexander, J. P., Gary, H. E., & Pallansch, M. A. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s176 · Cited by 170 · see citing works
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy.
Kilpatrick, D. R., Nottay, B., Yang, C. F., Yang, S. J., Mulders, M. N., Holloway, B. P., Pallansch, M. A., & Kew, O. M. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.2990-2996.1996 · Cited by 172 · see citing works
“However, evolution of the poliovaccines is usually limited because vaccine virus spread is typically restricted to vaccine recipients and their immediate contacts (4).”
Background
Poliovirus vaccine-live
Sutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167 · see citing works
Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern Nigeria
Burns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02954-12 · Cited by 153 · see citing works
Circulation of type 1 vaccine-derived poliovirus in the philippines in 2001
Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13512-13521.2004 · Cited by 146 · see citing works
Molecular Evolution of a Type 1 Wild-Vaccine Poliovirus Recombinant during Widespread Circulation in China
Liu, H.-M., Zheng, D.-P., Zhang, L.-B., Oberste, M. S., Pallansch, M. A., & Kew, O. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11153-11161.2000 · Cited by 119 · see citing works
Expert Review on Poliovirus Immunity and Transmission
Tebbens, R. J. D., Pallansch, M. A., Chumakov, K. M., Halsey, N. A., Hovi, T., Minor, P. D., Modlin, J. F., PATRIARCA, P. A., Sutter, R. W., Wright, P. F., et al. (2012) · Risk Analysis · doi:10.1111/j.1539-6924.2012.01864.x · Cited by 109 · see citing works
“Two studies(19,53) that include separate challenge arms for each serotype found no notable difference in the probability of excretion over time (Fig.”
Influential
Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom.
Halsey, N. A., Pinto, J. A., Espinosa-Rosales, F. J., Faure-Fontenla, M. A., da Silva, E., Khan, A. J., WEBSTER, A. D. B., Minor, P. D., Dunn, G., Asturias, E. J., et al. (2004) · Europe PMC (PubMed Central) · Cited by 106 · see citing works
Intratypic Recombination among Lineages of Type 1 Vaccine-Derived Poliovirus Emerging during Chronic Infection of an Immunodeficient Patient
Yang, C.-F., Chen, H., Jorba, J. C., Sun, H.-C., Yang, S.-J., Lee, H.-C., Huang, Y., Lin, T., Chen, P., Shimizu, H., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12623-12634.2005 · Cited by 104 · see citing works
Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine‐Derived Polioviruses (cVDPVs)
Tebbens, R. J. D., Pallansch, M. A., Kim, J., Burns, C. C., Kew, O. M., Oberste, M. S., Diop, O. M., Wassilak, S. G. F., Cochi, S. L., & Thompson, K. M. (2013) · Risk Analysis · doi:10.1111/risa.12022 · Cited by 101 · see citing works
“This would imply that secondary OPV spread can substantially improve population immunity induced by OPV through infection of close contacts(4,6,126) while remaining self-limited such that it does not lead to outbreaks.”
Background
Seroprevalence of Antibody Against Poliovirus in Inner-city Preschool Children
Chen, R. T. (1996) · JAMA · doi:10.1001/jama.1996.03530450029028 · Cited by 79 · see citing works
Identification of vaccine-related polioviruses by hybridization with specific RNA probes
De, L., Nottay, B. K., Yang, C. F., Holloway, B. P., Pallansch, M. A., & Kew, O. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.562-571.1995 · Cited by 78 · see citing works
Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria
Famulare, M., Chang, S. T., Iber, J. C., Zhao, K., Adeniji, J. A., Bukbuk, D. N., Baba, M., Behrend, M. R., Burns, C. C., & Oberste, M. S. (2015) · Journal of Virology · doi:10.1128/jvi.01532-15 · Cited by 72 · see citing works
“An alternative hypothesis that we cannot rule out is that our assumption that most of the samples are from primary vaccine recipients is more often false for type 2 due to higher levels of secondary spread of type 2 (6), and so we may be underestimating the range of times from the time of exposure to the time of sampl…”
BackgroundResult
Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation
Thompson, K. M., & Tebbens, R. J. D. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.195 · Cited by 72 · see citing works
Modeling Population Immunity to Support Efforts to End the Transmission of Live Polioviruses
Thompson, K. M., Pallansch, M. A., Tebbens, R. J. D., Wassilak, S. G. F., & Cochi, S. L. (2012) · Risk Analysis · doi:10.1111/j.1539-6924.2012.01891.x · Cited by 68 · see citing works
“(29−31) Close contacts appear more likely to become infected, although the infections can spread to community contacts as well.(27,32,33) Secondary spread of OPV offers the advantage of extending the impact of the”
Background
Estimating the Extent of Vaccine-Derived Poliovirus Infection
Wringe, A., Fine, P., Sutter, R. W., & Kew, O. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003433 · Cited by 68 · see citing works
The Association of the Temperature-Sensitive Phenotype with Viral Attenuation in Animals and Humans: Implications for the Development and Use of Live Virus Vaccines
Richman, D. D., & Murphy, B. R. (1979) · Clinical Infectious Diseases · doi:10.1093/clinids/1.3.413 · Cited by 68 · see citing works
“Since the correlation between the ts marker and attenuation is good but not complete [30, 157], the attenuation of these strains probably results from the cumulative effects of both ts and non-ts mutations.”
BackgroundInfluential
Environmental Surveillance of Poliovirus in Sewage Water around the Introduction Period for Inactivated Polio Vaccine in Japan
Nakamura, T., Hamasaki, M., Yoshitomi, H., Ishibashi, T., Yoshiyama, C., Maeda, E., Sera, N., & Yoshida, H. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.03575-14 · Cited by 62 · see citing works
“Because of the high rate of usage of disposable diapers, PVs from OPV-immunized children may be transmitted by familial contacts, such as siblings and parents, or contacts at school facilities, such as kindergarteners (38).”
Background
Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management.
Dowdle, W., Van Der Avoort, H., De Gourville, E., Delpeyroux, F., Desphande, J., Hovi, T., Martin, J., Pallansch, M., Kew, O., & Wolff, C. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00844.x · Cited by 61 · see citing works
“5/dose mOPV given orally) infects on average >90% of susceptibles,(8,59,85,96,187) indicating the formulation exceeds human CCID50.”
BackgroundInfluential
Poliovirus and Other Enteroviruses
Melnick, J. L. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0036-4_21 · Cited by 61 · see citing works
Self-citation
Prevalence of vaccine-derived polioviruses in the environment
Yoshida, H., Horie, H., Matsuura, K., Kitamura, T., Hashizume, S., & Miyamura, T. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-5-1107 · Cited by 54 · see citing works
“…in the human gut after OPV administration and the phenotype of excreted viruses changes from attenuated to virulent (Abraham et al., 1993 ; Dunn et al., 1990 ; Japan Live Poliovaccine Research Commission, 1967 ; Benyesh-Melnick et al., 1967 ; Guillot et al., 1994 ; Wood & Macadam, 1997).”
Background
Virus isolations from sewage and from a stream receiving effluents of sewage treatment plants.
Grinstein, S., Melnick, J. L., & Wallis, C. (1970) · PubMed · Cited by 56 · see citing works
Self-citation
Poliovirus vaccine—live
Sutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00035-5 · Cited by 55 · see citing works
Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan
Yoshida, H., Horie, H., Matsuura, K., & Miyamura, T. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02868-3 · Cited by 51 · see citing works
Modeling the Potential Role of Inactivated Poliovirus Vaccine to Manage the Risks of Oral Poliovirus Vaccine Cessation
Duintjer Tebbens, R. J., & Thompson, K. M. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit838 · Cited by 48 · see citing works
Infectivity liters of enterovirus as found in human stools
Melnick, J. L., & Rennick, V. (1980) · Journal of Medical Virology · doi:10.1002/jmv.1890050305 · Cited by 49 · see citing works
Self-citation
Rabies Viruses Increase in Virulence When Propagated in Neuroblastoma Cell Culture
Clark, H. F. (1978) · Science · doi:10.1126/science.628831 · Cited by 47 · see citing works
Mass Vaccination Campaigns for Polio Eradication: An Essential Strategy for Success
Sutter, R. W., & Maher, C. (2006) · Springer eBooks · doi:10.1007/3-540-36583-4_11 · Cited by 41 · see citing works
Poliomyelitis in the Netherlands: a review of population immunity and exposure between the epidemics in 1978 and 1992
Rümke, H. C., Oostvogel, P. M., van Steenis, G., & van Loon, A. M. (1995) · Epidemiology and Infection · doi:10.1017/s0950268800058416 · Cited by 38 · see citing works
“However, it is known that IPV-recipients can excrete PV after challenge with wild or vaccine virus [19, 20], and may contribute to faecal spread.”
Assessing the stability of polio eradication after the withdrawal of oral polio vaccine
Famulare, M., Selinger, C., McCarthy, K. A., Eckhoff, P. A., & Chabot‐Couture, G. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2002468 · Cited by 36 · see citing works
“This observation 722 supports the long-held hypothesis that oral-oral transmission is important in settings with high 723 socioeconomic status and corresponding good sanitation, supported by many observations that IPV 724 alone—an effective blocker of oral shedding [64,85]—can block transmission and prevent outbreaks…”
Background
… and in the United Kingdom
(1989) · Reactions Weekly · doi:10.1007/bf03283864 · Cited by 37 · see citing works
Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt.
Linkins, R. W., Mansour, E., Wassif, O. M., Hassan, M. H., & Patriarca, P. A. (1995) · Europe PMC (PubMed Central) · Cited by 36 · see citing works
Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study
Taniuchi, M., Famulare, M., Zaman, K., Uddin, M. J., Upfill-Brown, A. M., Ahmed, T., Saha, P., Haque, R., Bandyopadhyay, A. S., Modlin, J. F., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30358-4 · Cited by 34 · see citing works
Non-polio enterovirus isolation among families in Ulaanbaatar and Tov province, Mongolia: prevalence, intrafamilial spread, and risk factors for infection
Kuramitsu, M., Kuroiwa, C., Yoshida, H., MIYOSHI, M., Okumura, J., Shimizu, H., Narantuya, L., & Bat-Ochir, D. (2005) · Epidemiology and Infection · doi:10.1017/s0950268805004139 · Cited by 34 · see citing works
“jp) rate [4-13].”
Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation
Tebbens, R. J. D., Hampton, L. M., Wassilak, S. G. F., Pallansch, M. A., Cochi, S. L., & Thompson, K. M. (2016) · Journal of Vaccines & Vaccination · doi:10.4172/2157-7560.1000340 · Cited by 32 · see citing works
“This remains consistent with the known rapid reversion and high transmissibility of the attenuated serotype 2 poliovirus in OPV [32,36,37] and the corresponding model assumptions of short reversion times and high relative R0 values for serotype 2.”
BackgroundResult
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial
Wilkinson, A. L., Zaman, K., Hoque, M., Estívariz, C. F., Burns, C. C., Konopka‐Anstadt, J. L., Mainou, B. A., Kovacs, S., An, Q., Lickness, J. S., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00139-1 · Cited by 27 · see citing works
Sporadic Isolation of Sabin-Like Polioviruses and High-Level Detection of Non-Polio Enteroviruses during Sewage Surveillance in Seven Italian Cities, after Several Years of Inactivated Poliovirus Vaccination
Battistone, A., Buttinelli, G., Fiore, S., Amato, C., Bonomo, P., PATTI, A. M., Vulcano, A., Barbi, M., Binda, S., Pellegrinelli, L., et al. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.00108-14 · Cited by 29 · see citing works
Untitled work
Sutter (2000) · doi:10.1016/s0031-3955(05)70208-x · Cited by 28 · see citing works
Emergence and Localized Circulation of a Vaccine-Derived Poliovirus in an Isolated Mountain Community in Guangxi, China
Yan, D., Li, L., Zhu, S., Zhang, Y., An, J., Wang, D., Wen, N., Jorba, J. C., Liu, W. Y., Zhong, G., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00712-10 · Cited by 28 · see citing works
Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks
Estívariz, C. F., Kovacs, S., & Mach, O. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.03.027 · Cited by 26 · see citing works
“Sabin strains, especially type 2, may also spread and indirectly vaccinate contacts [15], which enhances the field effectiveness of OPV.”
Background
Lessons Learned From a Review of the Development of Selected Vaccines
Committee, N. V. A. (1999) · PEDIATRICS · doi:10.1542/peds.104.4.942 · Cited by 34 · see citing works
Poliomyelitis and Poliovirus Immunization
Modlin, J. F. (2014) · ASM Press eBooks · doi:10.1128/9781555818326.ch9 · Cited by 24 · see citing works
Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan
Tebbens, R. J. D., & Thompson, K. M. (2018) · Risk Analysis · doi:10.1111/risa.13194 · Cited by 23 · see citing works
“Serotype 1 VDPV outbreaks may prove more difficult to control after OPV cessation than serotype 2 VDPV outbreaks due to the higher transmissibility and lower secondary OPV benefits for serotype 1 than for serotype 2 (Benyesh-Melnick et al., 1967; Duintjer Tebbens & Thompson, 2017a), particularly if the declaration of…”
Background
Environmental Surveillance Can Dynamically Track Ecological Changes in Enteroviruses
Ozawa, H., Yoshida, H., & Usuku, S. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.01604-19 · Cited by 23 · see citing works
“Echo25 (50), Echo3 (40), CB3 (11), and Echo7 (7).”
BackgroundInfluential
COVID-19 Infection Among Women in Iran Exposed vs Unexposed to Children Who Received Attenuated Poliovirus Used in Oral Polio Vaccine
Habibzadeh, F., Sajadi, M. M., Chumakov, K., Yadollahie, M., Kottilil, S., Simi, A., Stafford, K. A., Saeidimehr, S., Rafiei, M., & Gallo, R. C. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.35044 · Cited by 22 · see citing works
“The crude incidence rate varied from month to month, with 2 peaks in June to July and October to November (eFigure 2 in the Supplement); incidence was always higher in Ahwaz than Shiraz (median [IQR], 15 [13-24] per 10 000 population in a month vs 10 [4-11] per 10 000 population in a month).”
Isolation of vaccine‐derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan
Horie, H., Yoshida, H., Matsuura, K., Miyazawa, M., Wakabayashi, K., Nomoto, A., & Hashizume, S. (2002) · Journal of Medical Virology · doi:10.1002/jmv.10224 · Cited by 23 · see citing works
“It has been reported that excreted viruses have mutations that develop during replication in the human intestinal tract [Benyesh-Melnick et al., 1967; Dunn et al., 1990; Mulders et al., 1999].”
Background
Use of oral polio vaccine and the incidence of COVID-19 in the world
Habibzadeh, F., Chumakov, K., Sajadi, M. M., Yadollahie, M., Stafford, K. A., Simi, A., Kottilil, S., Hafizi-Rastani, I., & Gallo, R. C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265562 · Cited by 22 · see citing works
Enteroviruses
Melnick, J. L. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0705-1_9 · Cited by 22 · see citing works
Self-citation
Community Circulation Patterns of Oral Polio Vaccine Serotypes 1, 2, and 3 After Mexican National Immunization Weeks
Troy, S. B., Ferreyra-Reyes, L. D., Huang, C., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit831 · Cited by 21 · see citing works
“United States conducted between 1957 and 1960, which examined shedding in household contacts of recipients of older formulations of trivalent OPV [15–17].”
Background
Impact of Supplementary Immunization Activities using Novel Oral Polio Vaccine Type 2 during a Large outbreak of Circulating Vaccine-Derived Poliovirus in Nigeria
Voorman, A., Lyons, H. M., Shuaib, F. M. B., Adamu, U. S., Korir, C., Erbeto, T. B., Bandyopadhyay, A. S., & Okiror, S. O. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad222 · Cited by 20 · see citing works
“Relative to types 1 and 3, the higher primary immunogenicity of the type 2 component of trivalent OPV (tOPV) and higher rates of Sabin 2 infection among contacts of vaccinees both contribute to this [14,15].”
Background
The Potential Benefits of a new Poliovirus Vaccine for Long-Term Poliovirus Risk Management
Tebbens, R. J. D., & Thompson, K. M. (2016) · Future Microbiology · doi:10.2217/fmb-2016-0126 · Cited by 21 · see citing works
Poliovirus Vaccine–Live
Sutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00048-1 · Cited by 22 · see citing works
A quantitative survey of the literature on poliovirus infection and immunity
Behrend, M. R., Hu, H., Nigmatulina, K. R., & Eckhoff, P. A. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.09.005 · Cited by 19 · see citing works
Live Attenuated Oral Poliovirus Vaccine
Melnick, J. L. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s323 · Cited by 19 · see citing works
“As mentioned above, the theoretical possibility of reversion of an attenuated live virus to greater virulence was obviously one of the primary concerns from the beginning of development of vaccine strains, and stability of the strains after replication was one of the most important properties sought in such strains [7…”
BackgroundSelf-citation
Evaluation of five temperature‐sensitive mutants of respiratory syncytial virus in primates: II. Genetic analysis of virus recovered during infection
Belshe, R. B., Richardson, L. S., London, W. T., et al. (1978) · Journal of Medical Virology · doi:10.1002/jmv.1890030203 · Cited by 19 · see citing works
Neurovirulence tests of type 3 oral poliovirus vaccine manufactured by Lederle Laboratories, 1964–1988
Nathanson, N., & Horn, S. D. (1992) · Vaccine · doi:10.1016/0264-410x(92)90396-2 · Cited by 18 · see citing works
Sequential Use of Inactivated Poliovirus Vaccine followed by Oral Poliovirus Vaccine in Oman
Sutter, R. W., Suleiman, A. J. M., Malankar, P., Mehta, F. R., Medany, M. A., Arif, M. A. M., Linkins, R. W., Pallansch, M. A., Elbualy, M. S., & Robertson, S. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s235 · Cited by 17 · see citing works
Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
(1969) · PubMed · Cited by 17 · see citing works
Genotype-specific RNA probes for direct identification of wild polioviruses by blot hybridization
De, L., Yang, C. F., Silva, E. D., Boshell, J., Cáceres, P., Gómez, J. R., Pallansch, M. A., & Kew, O. M. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.11.2834-2840.1997 · Cited by 15 · see citing works
“Moreover, evolution of the poliovirus vaccine strains is generally limited, because excretion of vaccine virus normally lasts 4 to 6 weeks (1) and virus spread is usually restricted to the immediate contacts of vaccine recipients (2).”
Background
Poliomyelitis surveillance in England and Wales, 1965–8
Miller, D. L., Reid, D. D., & Diamond, J. R. (1970) · Public Health · doi:10.1016/s0033-3506(70)80065-8 · Cited by 16 · see citing works
Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
Mohanty, M. C., Madkaikar, M. R., Desai, M., Taur, P. D., Nalavade, U. P., Sharma, D. K., Gupta, M., Dalvi, A. D., Shabrish, S., Kulkarni, M., et al. (2017) · Emerging infectious diseases · doi:10.3201/eid2310.170724 · Cited by 15 · see citing works
Neurovirulence of Type 1 Polioviruses Isolated from Sewage in Japan
Horie, H., Yoshida, H., Matsuura, K., Miyazawa, M., Ota, Y., Nakayama, T., Doi, Y., & Hashizume, S. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.1.138-142.2002 · Cited by 15 · see citing works
Estimating the Risk of Re-Emergence after Stopping Polio Vaccination
Sasaki, A., Haraguchi, Y., & Yoshida, H. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00178 · Cited by 14 · see citing works
“While the probability of within-family infection was estimated to be 0.5 per case (Benyesh-Melnick et al., 1967), we also needed to evaluate the mean transmission rate to other members of the community.”
BackgroundInfluential
Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?
Devaux, C. A., Pontarotti, P., Levasseur, A., Colson, P., & Raoult, D. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1284337 · Cited by 16 · see citing works
Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules
Bandyopadhyay, A. S., Asturias, E. J., O’Ryan, M., Oberste, M. S., Weldon, W. C., Clemens, R. L., Rüttimann, R. W., Modlin, J. F., & Gast, C. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.11.006 · Cited by 13 · see citing works
“The magnitude of this difference in viral shedding may be expected to provide a substantial reduction in virus transmission compared with that provided by bOPV–IPV regimens, although only limited data are available to directly link dynamics of viral shedding to transmission [40,41].”
Background
Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage
Altamirano, J., Purington, N., Behl, R., Sarnquist, C., Holubar, M. K., García‐García, L., Ferreyra-Reyes, L. D., Montero-Campos, R., Cruz‐Hervert, L. P., Boyle, S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy650 · Cited by 12 · see citing works
“OPV recipients shed vaccine virus in their stool, which confers herd immunity, considered to be among the greatest attributes of the vaccine [1].”
Background
Optimal schedule for the administration of oral poliovirus vaccine
PATRIARCA, P. A., Linkins, R. W., Sutter, R. W., & Orenstein, W. A. (1993) · Springer eBooks · doi:10.1007/978-3-7091-9278-8_25 · Cited by 16 · see citing works
The Mechanism of Poliovirus Eradication
Kew, O. M., & Pallansch, M. A. (2014) · ASM Press eBooks · doi:10.1128/9781555817916.ch39 · Cited by 12 · see citing works
Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization
Sarnquist, C., Holubar, M. K., García‐García, L., Ferreyra-Reyes, L. D., Delgado-Sánchez, G., Cruz‐Hervert, L. P., Montero-Campos, R., Altamirano, J., Purington, N., Boyle, S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy606 · Cited by 9 · see citing works
“Data on community spread of vaccine-derived poliovirus suggest about a 20% community transmission rate, but are mostly from the United States and from the 1950’s and 1960’s; thus, there is a gap in the current understanding [13, 14].”
Background
Markers and Vaccines
Kańtoch, M. (1978) · Advances in virus research · doi:10.1016/s0065-3527(08)60776-9 · Cited by 8 · see citing works
Shedding of Oral Poliovirus Vaccine (OPV) by HIV-Infected and -Uninfected Mothers of OPV-Vaccinated Zimbabwean Infants
Holubar, M. K., Troy, S. B., Nathoo, K., Stranix‐Chibanda, L., Musingwini, G., Srinivas, N., Huang, C., Junn, A., Halpern, M. S., & Maldonado, Y. (2016) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piv083 · Cited by 6 · see citing works
Use of Oral Polio Vaccine and the Global Incidence of Mother-to-Child Human Immunodeficiency Virus Transmission
Habibzadeh, F., Yadollahie, M., & Simi, A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.878298 · Cited by 7 · see citing works
“This can initiate chains of transmission resulting in exposure of a significant number of people to the attenuated poliovirus, particularly in environments with poor sanitation (most probably countries with lower HDI) (29).”
Background
Assessing the individual risk of fecal poliovirus shedding among vaccinated and non-vaccinated subjects following national health weeks in Mexico
Ferreyra-Reyes, L. D., Cruz‐Hervert, L. P., Troy, S. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185594 · Cited by 7 · see citing works
Enteroviruses
Melnick, J. L. (1991) · Springer eBooks · doi:10.1007/978-1-4615-8138-3_9 · Cited by 6 · see citing works
Self-citation
Deep sequencing prompts the modification of a real-time RT-PCR for the serotype-specific detection of polioviruses
Holubar, M. K., Sahoo, M. K., Huang, C., Mohamed-Hadley, A. A., Liu, Y., Waggoner, J. J., Troy, S. B., García‐García, L., Ferreyra-Reyes, L. D., Maldonado, Y., et al. (2018) · Journal of Virological Methods · doi:10.1016/j.jviromet.2018.11.007 · Cited by 5 · see citing works
“Historical studies showed that up to ninety percent of infants shed OPV after vaccination and can spread OPV to their household contacts (Benyesh-Melnick et al., 1967).”
Background
Acquisition of immunity in mothers of infants administered trivalent oral poliovirus vaccine
Dagan, R., Fraser, D., & Handsher, R. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02111822 · Cited by 5 · see citing works
Oral Polio Vaccine and the Results of Its Use
Melnick, J. L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1339-5_19 · Cited by 3 · see citing works
Self-citation
Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine
Jarvis, C. I., Altamirano, J., Sarnquist, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy622 · Cited by 3 · see citing works
“Low levels of transmission also occur as quickly as 1 week after vaccination, as shown by transmissibility trials from the 1960s, the results which are corroborated by more recent work in Zimbabwe looking at human immunodeficiency virus–infected mothers with OPV-vaccinated children [17–20].”
Result
[Intratypic serological identification of poliovirus by the method of comparison of neutralization indices].
Stewien, K. E. (1971) · PubMed · Cited by 3 · see citing works
Identificação sorológica intratípica de poliovírus pelo "método da comparação dos índices de neutralização"
Stewien, K. E. (1971) · Revista de Saúde Pública · doi:10.1590/s0034-89101971000200007 · Cited by 3 · see citing works
Does oral polio vaccine at birth affect the size of the thymus? Observations within a randomized trial
Eriksen, H. B., Lund, N., Biering-Sørensen, S. R., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.03.082 · Cited by 2 · see citing works
Classical Live Viral Vaccines
Thomas (2010) · Springer eBooks · doi:10.1007/978-3-0346-0277-8_3 · Cited by 2 · see citing works
“Between 70 and 90% of infants undergoing primary immunization with oral polio vaccine excrete virus in feces [38].”
Background
High population immunity reduces poliovirus community transmission
Garon, J. R., Sutter, R. W., & Orenstein, W. A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30417-6 · Cited by 2 · see citing works
Poliovirus Vaccine–Live
Estívariz, C. F., Burns, C. C., & Macklin, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00050-5 · Cited by 2 · see citing works
Immunity to poliovirus after infection and vaccination
Herremans, M. M. P. T. (1999) · Utrecht University Repository (Utrecht University) · Cited by 1 · see citing works
Application of Serological, Virological, and Genetic Marker Studies for the Determination of Virus Distribution
Kańtoch, M., Nawrocka, E., & Jarzabek, Z. (1978) · Elsevier eBooks · doi:10.1016/b978-0-12-429766-1.50025-x · Cited by 1 · see citing works
Winning the war against paralytic poliomyelitis
Wegmann, A., & Glück, R. (1995) · European Journal of Pediatrics · doi:10.1007/bf02276710
Polioviruses and the Endgame Strategy for Global Polio Eradication
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005)
Dynamics of genomic variation in poliovirus in Africa
Chezzi, C. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
12. Scale in Disease Transmission, Surveillance, and Modeling
Chabot‐Couture, G. (2016) · CRC Press eBooks · doi:10.1201/9781315373720-13
Occurrence of enteric viruses in disposable diapers from three landfills
Huber, M. S. (1992) · UA Campus Repository (The University of Arizona)

Authors: BENYESH-MELNICK, M., MELNICK, J. L., RAWLS, W. E., WIMBERLY, I., ORO, J. B., BEN-PORATH, E., & RENNICK, V.
Venue: American Journal of Epidemiology
Publisher: Oxford University Press (OUP)
Published: 1967-07
Volume: 86
Issue: 1
Pages: 112-136
ISSN: 0002-9262 (ISSN-L)
1476-6256
DOI: 10.1093/oxfordjournals.aje.a120717
OpenAlex: W2418837549
Cited by: 93
References: 0
Citations by year: 2024: 1 · 2023: 3 · 2022: 3 · 2021: 1 · 2019: 1 · 2018: 6 · 2017: 6 · 2016: 4 · 2015: 2 · 2014: 6 · 2013: 5 · 2012: 4
FWCI: 1.75
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Epidemiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
Keywords: poliomyelitis, immunogenicity, transmissibility, genetic stability, vaccine virus, live attenuated virus
MeSH terms: Antibodies, Viral, Female, Humans, Infant, Infant, Newborn, Male, Mexico, Poliovirus Vaccine, Oral, Seasons, Vaccines, Attenuated, Poliovirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

STUDIES OF THE IMMUNOGENICITY, COMMUNICABILITY AND GENETIC STABILITY OF ORAL POLIOVACCINE ADMINISTERED DURING THE WINTER1

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cited by

Related

Record

About these checks